RESUMO
We report a case of calcific tendinitis of the Longus Colli muscle. We reviewed the differencial diagnosis and performed a literature search. To our knowledge this is the first Chilean report on this unusual disease.
Nosotros reportamos un caso de Tendinitis cálcica del músculo Longus Colli. Se revisa la literatura y los diagnósticos diferenciales. Se trata de una enfermedad infrecuente, según nuestro conocimiento sería el primer caso reportado en la literatura chilena.
Assuntos
Humanos , Adulto , Feminino , Calcinose , Doenças Faríngeas , Tendinopatia , Calcinose/terapia , Diagnóstico Diferencial , Cervicalgia/etiologia , Doenças Faríngeas/terapia , Tendinopatia/terapiaAssuntos
Humanos , Credenciamento , Educação Médica/normas , Avaliação Educacional , Chile , Docentes de Medicina , Sociedades MédicasRESUMO
Dado el desarrollo en el tratamiento del cáncer, el cirujano ortopédico se ve enfrentado cada vez con mayor frecuencia a la aparición de metástasis vertebrales en la columna. Aún en publicaciones actuales, su manejo es controvertido. Se revisa la literatura buscando la evidencia que existe en el tratamiento de esta patología y se formula una propuesta de algoritmo para su manejo por parte del cirujano ortopédico
Assuntos
Humanos , Procedimentos Ortopédicos/métodos , Neoplasias da Coluna Vertebral , Laminectomia , Metástase Neoplásica , Prognóstico , Síndromes de Compressão Nervosa/etiologia , Neoplasias da Coluna VertebralRESUMO
Systemic thrombolysis is an effective therapy for acute myocardial infarction, since it restores coronary flow and contributes to preserve left ventricular function. We analyzeour experience with intravenous thrombolytic therapy in 45 cases with acute myocardialinfarction treated within 6 hours of onset of symptoms. 28 patients had anterior and 17 inferior myocardial infarction. We treated 38 patients with streptokinase 1 to 1,5 million units infused during a during a 30 to 60 minute period and 7 patients with tissue plasminogen activator factor, 100 mg infused during 2 hours. Regression of chest pain and ST segment elevation and early CPK peaking (< 4 hours) were utilized as criteria for reperfusion. Accordingly 20 patients (64%) met these criteria. Coronary angiogram ws performed within 7 days in 38 patients. It disclosed a patent coronary artery in the infarcted area in 28 cases (74%). Transient hypotension with thrombolytic therapy was observed in 17 patients (38%) and bleeding complications in 3 cases (7%). Two patients (4%) died early after therapeutic failure. In summary we have confirmed that intravenous thrombolytic therapy is safe and effective in the early period of myocardial infarction and that is associated with a high incidence of clinical and angiographic reperfusion